HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Difficulties in the diagnosis and differential diagnosis of panniculitis in therapeutic practice

DOI: https://doi.org/10.29296/25877305-2022-05-10
Issue: 
5
Year: 
2022

Professor O. Kozyrev(1), MD; I. Bazina(1), Candidate of Medical Sciences;
D. Krechikova(2), Candidate of Medical Sciences; I. Korneeva(2), E. Vinogradova(1),
A. Mayorova(1), O. Makarova(1),
1-Smolensk State Medical University
2-Departmental Hospital at the Smolensk Station, OAO “RZhD”

Panniculitides are called a group of diseases that are dissimilar in etiology and clinical and morphological patterns, the main manifestation of which is inflammation of subcutaneous adipose tissue to form skin nodules. Diagnosis in therapeutic practice is complicated by the need for an extensive examination for differential diagnosis and exclusion of other diseases. The paper considers a clinical case of a female patient with panniculitis, the complexity of its diagnosis and differential diagnosis.

Keywords: 
therapy
panniculitis
differential diagnosis
ureteral motility
α2-adrenergic receptor
TXA2 receptor



References: 
  1. Belov B.S., Egorova O.N., Savushkina N.M. et al. Panniculitides in an internist’s practice. Ter Arkh. 2014; 86 (5): 88–93 (in Russ.).
  2. Egorova O.N., Belov B.S. Pannikulity: problemy differentsial’noi diagnostiki. RMJ. 2011; 10: 601 (in Russ.).
  3. Usacheva M.N., Cherkasova E.G., Babaeva A.R. Clinical and morphological features of erythema nodosum and panniculitis. Volgogradskii nauchno-meditsinskii zhurnal. 2017; 1: 50–5 (in Russ.).
  4. Requena L., Yus E.S. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001; 45 (2): 163–83. DOI: 10.1067/mjd.2001.114736
  5. Campschroer T., Zhu X., Vernooij R.W.M. et al. α-Blockers as medical expulsive therapy for ureteric stones: a Cochrane systematic review. BJU Int. 2018; 122 (6): 932–45. DOI: 10.1111/bju.14454
  6. Liyan Xu, Yan W. Combined influence of ABCB1 genetic polymorphism and DNA methylation on aspirin resistance in Chinese ischemic stroke patients. Acta Neurol Belg. 2021Online ahead of print. DOI: 10.1007/s13760-021-01714-1
  7. Al-Sofiani M.E., Yanek L.R., Faraday N. еt al. Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab. 2018; 103 (12): 4599–608. DOI: 10.1210/jc.2018-01254
  8. Chaignat V., Danuser H., Stoffel M.H. еt al. Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo. Br J Pharmacol. 2008; 154 (6): 1297–307. DOI: 10.1038/bjp.2008.193
  9. Nørregaard R., Jensen B.L., Topcu S.O. еt al. Cyclooxygenase type 2 is increased in obstructed rat and human ureter and contributes to pelvic pressure increase after obstruction. Kidney Int. 2006; 70 (5): 872–81. DOI: 10.1038/sj.ki.5001616
  10. Lee S.Y., Lee M.Y., Park S.H. et al. NS-398 (a selective cyclooxygenase-2 inhibitor) decreases agonist-induced contraction of the human ureter via calcium channel inhibition. J Endourol. 2010; 24 (11): 1863–8. DOI: 10.1089/end.2009.0461
  11. Wang H., Sun X., Dong W. еt al. Association of GPIa and COX-2 gene polymorphism with aspirin resistance. J Clin Lab Anal. 2018; 32 (4): e22331. DOI: 10.1002/jcla.22331
  12. Jerde T.J., Calamon-Dixon J.L., Bjorling D.E. et al. Celecoxib inhibits ureteral contractility and prostanoid release. Urology. 2005; 65 (1): 185–90. DOI: 10.1016/j.urology.2004.08.057
  13. Huang Z.A., Scotland K.B., Li Y. еt al. Determination of urinary prostaglandin E2 as a potential biomarker of ureteral stent associated inflammation. J Chromatogr B Analyt Technol Biomed Life Sci. 2020; 1145: 122107. DOI: 10.1016/j.jchromb.2020.122107
  14. Luo R., Kakizoe Y., Wang F. еt al. Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2017; 312 (1): F121-F133. DOI: 10.1152/ajprenal.00231.2016
  15. Motiejunaite J., Amar L., Vidal-Petiot E. Adrenergic receptors and cardiovascular effects of catecholamines. Ann Endocrinol (Paris). 2021; 82 (3-4): 193–7. DOI: 10.1016/j.ando.2020.03.012
  16. Monks D.R., Bund S.J. The modulation of ureteral smooth muscle contractile responses by α1- and α2-adrenoceptor activation. Physiol Int. 2018; 105 (3): 225–32. DOI: 10.1556/2060.105.2018.3.19
  17. Hering L., Rahman M., Hoch H. еt al. α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease. J Am Soc Nephrol. 2020; 31 (4): 783–98. DOI: 10.1681/ASN.2019060599
  18. Park Y.C., Tomiyama Y., Hayakawa K. еt al. Existence of a beta3-adrenoceptro and its functional role in the human ureter. J Urol. 2000; 164 (4): 1364–70.